Showing results (141-150 of 212) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2021
Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown PrimaryKanwal Raghav, Hyunsoo Hwang, Alexandre A Jácome, et al.
Journal for Immunotherapy of Cancer|January 4, 2025
Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitorsJulien Taieb, Margherita Ambrosini, Emily Alouani, et al.
JAMA Network Open|May 17, 2023
Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical TrialsMarcus A Florez, Joseph Abi Jaoude, Roshal R Patel, et al.
The Oncologist|April 14, 2026
Mucinous histology and resistance to immune checkpoint blockade in patients with microsatellite instability-high metastatic colorectal cancerVincenzo Nasca, Margherita Ambrosini, Julien Taieb, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 6, 2025
Mutational and co-mutational landscape of early onset colorectal cancerJumanah Yousef Alshenaifi, Guglielmo Vetere, Giulia Maddalena, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 7, 2017
Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicityRanda Tao, Chiaojung Jillian Tsai, Garrett Jensen, et al.
Cancer Research Communications|May 6, 2024
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal AdenocarcinomaNicholas J Hornstein, Mohammad A Zeineddine, Betul B Gunes, et al.
The Oncologist|August 20, 2025
First-line PD-1 +/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancerVincenzo Nasca, Gabriele Tinè, Julien Taieb, et al.
Molecular Cancer Therapeutics|May 5, 2017
Modeling of Patient-Derived Xenografts in Colorectal CancerAnastasia Katsiampoura, Kanwal Raghav, Zhi-Qin Jiang, et al.
JCO Precision Oncology|February 1, 2022
Validation of <i>HER2</i> Amplification as a Predictive Biomarker for Anti-Epidermal Growth Factor Receptor Antibody Therapy in Metastatic Colorectal CancerKanwal Raghav, Jonathan M Loree, Jeffrey S Morris, et al.
Pageof 22